ClinicalMetric tracks all active clinical trials for adhd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — adhd Clinical Trials
How many clinical trials are currently recruiting for adhd?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for adhd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for adhd?
adhd research spans Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a adhd clinical trial?
Eligibility criteria for adhd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3 2
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06109337
Recruiting
Enrollment
100 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
NCT07717892 Phase 3
Recruiting
Enrollment
468 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
NCT07784348
Recruiting
Enrollment
120 pts
Location
United States
Sponsor
Florida State University
NCT07281092
Recruiting
Enrollment
36 pts
Location
United States
Sponsor
Seattle Children's Hospital
NCT06330779
Recruiting
Enrollment
180 pts
Location
Sweden
Sponsor
University West, Sweden
NCT07389473
Recruiting
Enrollment
50 pts
Location
United States
Sponsor
Gaize
NCT06299189
Recruiting
Enrollment
200 pts
Location
Norway
Sponsor
Haukeland University Hospital
NCT07162831
Recruiting
Enrollment
40 pts
Location
Switzerland
Sponsor
Insel Gruppe AG, University Ho...
NCT06378281
Recruiting
Enrollment
100 pts
Location
Switzerland
Sponsor
Stéphanie Baggio
NCT06808425
Recruiting
Enrollment
200 pts
Location
Sweden
Sponsor
Halmstad University
NCT07595783
Recruiting
Enrollment
40 pts
Location
Germany
Sponsor
Bielefeld University
NCT07380412
Recruiting
Enrollment
90 pts
Location
United States
Sponsor
Outliers, Inc.
NCT04526600
Recruiting
Enrollment
109 pts
Location
United States
Sponsor
University of California, Davi...
NCT04216186 Phase 3
Recruiting
Enrollment
40 pts
Location
Egypt
Sponsor
Sherief Abd-Elsalam
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology